Double-Blind Comparison of Iodamide and Diatrizoate for Excretory Urography

A double-blind comparison of meglumine iodamide and Renografin 60 (52% meglumine diatrizoate and 8% sodium diatrizoate) for bolus excretory urography was performed. Doses of 0.8 cc/kg. to a maximum of 55 cc were administered to fifty patients, twenty-five receiving each drug. There is a suggestion t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenfield, Arthur T., Putman, Charles E., Ulreich, Sidney, Koss, Neal
Formato: Texto
Lenguaje:English
Publicado: 1977
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2595582/
https://www.ncbi.nlm.nih.gov/pubmed/345632
_version_ 1782161719938777088
author Rosenfield, Arthur T.
Putman, Charles E.
Ulreich, Sidney
Koss, Neal
author_facet Rosenfield, Arthur T.
Putman, Charles E.
Ulreich, Sidney
Koss, Neal
author_sort Rosenfield, Arthur T.
collection PubMed
description A double-blind comparison of meglumine iodamide and Renografin 60 (52% meglumine diatrizoate and 8% sodium diatrizoate) for bolus excretory urography was performed. Doses of 0.8 cc/kg. to a maximum of 55 cc were administered to fifty patients, twenty-five receiving each drug. There is a suggestion that iodamide may be superior to diatrizoate in pyelocalyceal opacification while being equal to diatrizoate in parenchymal opacification and in types and severity of side-effects.
format Text
id pubmed-2595582
institution National Center for Biotechnology Information
language English
publishDate 1977
record_format MEDLINE/PubMed
spelling pubmed-25955822008-12-05 Double-Blind Comparison of Iodamide and Diatrizoate for Excretory Urography Rosenfield, Arthur T. Putman, Charles E. Ulreich, Sidney Koss, Neal Yale J Biol Med Original Contributions A double-blind comparison of meglumine iodamide and Renografin 60 (52% meglumine diatrizoate and 8% sodium diatrizoate) for bolus excretory urography was performed. Doses of 0.8 cc/kg. to a maximum of 55 cc were administered to fifty patients, twenty-five receiving each drug. There is a suggestion that iodamide may be superior to diatrizoate in pyelocalyceal opacification while being equal to diatrizoate in parenchymal opacification and in types and severity of side-effects. 1977 /pmc/articles/PMC2595582/ /pubmed/345632 Text en
spellingShingle Original Contributions
Rosenfield, Arthur T.
Putman, Charles E.
Ulreich, Sidney
Koss, Neal
Double-Blind Comparison of Iodamide and Diatrizoate for Excretory Urography
title Double-Blind Comparison of Iodamide and Diatrizoate for Excretory Urography
title_full Double-Blind Comparison of Iodamide and Diatrizoate for Excretory Urography
title_fullStr Double-Blind Comparison of Iodamide and Diatrizoate for Excretory Urography
title_full_unstemmed Double-Blind Comparison of Iodamide and Diatrizoate for Excretory Urography
title_short Double-Blind Comparison of Iodamide and Diatrizoate for Excretory Urography
title_sort double-blind comparison of iodamide and diatrizoate for excretory urography
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2595582/
https://www.ncbi.nlm.nih.gov/pubmed/345632
work_keys_str_mv AT rosenfieldarthurt doubleblindcomparisonofiodamideanddiatrizoateforexcretoryurography
AT putmancharlese doubleblindcomparisonofiodamideanddiatrizoateforexcretoryurography
AT ulreichsidney doubleblindcomparisonofiodamideanddiatrizoateforexcretoryurography
AT kossneal doubleblindcomparisonofiodamideanddiatrizoateforexcretoryurography

Ejemplares similares